Journey Enterprise Value Over E B I T D A from 2010 to 2024

DERM Stock  USD 4.70  0.02  0.43%   
Journey Medical Enterprise Value Over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value Over EBITDA is likely to grow to 20.32 this year. During the period from 2010 to 2024, Journey Medical Enterprise Value Over EBITDA quarterly data regression pattern had range of 27.4527 and standard deviation of  9.92. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
19.35223365
Current Value
20.32
Quarterly Volatility
9.92366991
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Journey Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Journey Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4 M, Interest Expense of 1.6 M or Selling General Administrative of 53.8 M, as well as many indicators such as Price To Sales Ratio of 1.26, Dividend Yield of 0.0 or PTB Ratio of 3.5. Journey financial statements analysis is a perfect complement when working with Journey Medical Valuation or Volatility modules.
  
Check out the analysis of Journey Medical Correlation against competitors.

Latest Journey Medical's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Journey Medical Corp over the last few years. It is Journey Medical's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Journey Medical's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Journey Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean4.50
Coefficient Of Variation220.38
Mean Deviation8.35
Median(0.24)
Standard Deviation9.92
Sample Variance98.48
Range27.4527
R-Value0.57
Mean Square Error71.41
R-Squared0.33
Significance0.03
Slope1.27
Total Sum of Squares1,379

Journey Enterprise Value Over E B I T D A History

2024 20.32
2023 19.35
2022 -0.9
2021 -1.78
2020 16.59
2019 24.34
2018 -2.96

About Journey Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Journey Medical income statement, its balance sheet, and the statement of cash flows. Journey Medical investors use historical funamental indicators, such as Journey Medical's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Journey Medical investors may use each financial statement separately, they are all related. The changes in Journey Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Journey Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Journey Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Journey Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 19.35  20.32 

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Journey Medical Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in Journey Stock

When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:
Check out the analysis of Journey Medical Correlation against competitors.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.17)
Revenue Per Share
4.273
Quarterly Revenue Growth
0.067
Return On Assets
0.0042
Return On Equity
(0.41)
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.